CircPTPRA competitively binds to the KH domain of IGF2BP1, interfering with its interaction with the downstream targets Myc and FSCN1 mRNA, thus inhibiting the growth and invasiveness of breast cancer cells [155]. This evidence concerns the gene IGF2BP1 and breast carcinoma.